baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

RBI Call/FACC 23-25/ AT0000A37BB3 /

2024-10-04 9:15:00 AM	Chg.0.000	Bid5:27:32 PM	Ask5:27:32 PM	Underlying	Strike price	Expiration date	Option type
0.056EUR	0.00%	- Bid Size: -	- Ask Size: -	FACC AG INH.AKT.	6.50 EUR	2025-03-21	Call

GlobeNewswire 08-26 Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

GlobeNewswire 08-14 19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...

GlobeNewswire 08-13 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...

GlobeNewswire 08-12 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 08-08 Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...

GlobeNewswire 07-31 BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

GlobeNewswire 07-28 Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...

GlobeNewswire 07-18 HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...

GlobeNewswire 07-17 Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...

GlobeNewswire 07-10 Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...

GlobeNewswire 07-09 New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

GlobeNewswire 07-08 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...

GlobeNewswire 06-17 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...

GlobeNewswire 06-12 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...

GlobeNewswire 06-10 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer

GlobeNewswire 06-05 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

GlobeNewswire 06-04 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...

GlobeNewswire 05-17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire 05-17 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...

GlobeNewswire 05-16 CVRx Announces Key Senior Leadership Team Hires

GlobeNewswire 05-15 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

GlobeNewswire 05-15 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...

GlobeNewswire 05-07 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...

GlobeNewswire 05-07 Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina

GlobeNewswire 05-02 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...

RBI Call/FACC 23-25/ AT0000A37BB3 /

If you wish to receive reply to your feedback, please provide your email address.